FMR LLC filed Amendment No. 7 to its Schedule 13G with the SEC on November 4, 2026, disclosing beneficial ownership of 32,089,434 shares of Structure Therapeutics Inc common stock as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: FMR LLC reported 32,089,434 shares of Structure Therapeutics Inc common stock, representing 15.0% of the class.
  • Sole voting power: FMR LLC holds sole voting power over 32,089,422 shares, according to the filing.
  • Sole dispositive power: FMR LLC holds sole dispositive power over 32,089,434 shares, with no shared dispositive power reported.
  • Abigail P. Johnson: Also named as a reporting person, she reported 32,089,434 shares beneficially owned, all through sole dispositive power, with zero sole or shared voting power listed in her name.
  • Event date: The filing is triggered by an event dated September 30, 2026, and was signed November 4, 2026.
  • No controlling interest claimed: The filing certifies that the securities "were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."

FMR LLC and Abigail P. Johnson Disclose Large Passive Stake in Structure Therapeutics

FMR LLC, a Delaware-organized holding company headquartered at 245 Summer Street, Boston, Massachusetts, submitted Amendment No. 7 to its Schedule 13G regarding its holdings in Structure Therapeutics Inc (CUSIP 86366E106), whose principal offices are located at 601 Gateway Blvd, Suite 900, South San Francisco, California 94080. The filing covers common stock and was triggered by an event dated September 30, 2026.

According to the filing, FMR LLC beneficially owns 32,089,434 shares, equal to 15.0% of the outstanding class. FMR LLC reports sole voting power over 32,089,422 shares and sole dispositive power over 32,089,434 shares. No shared voting or shared dispositive power is reported for FMR LLC. Abigail P. Johnson, a United States citizen, is also listed as a reporting person and discloses the same aggregate beneficial ownership of 32,089,434 shares, entirely through sole dispositive power, with no voting power attributed to her directly.

The filing notes that one or more other persons have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the common stock of Structure Therapeutics Inc, but states that no single other person's interest exceeds five percent of the total outstanding common stock. The document was signed by Stephanie J. Brown under powers of attorney granted by FMR LLC and Abigail P. Johnson, effective January 3, 2023, and January 26, 2023, respectively. An Exhibit 99 is referenced for subsidiary identification details.

What Was Disclosed

FMR LLC and Abigail P. Johnson filed Amendment No. 7 to Schedule 13G disclosing combined beneficial ownership of 32,089,434 shares, or 15.0%, of Structure Therapeutics Inc common stock, based on a triggering event of September 30, 2026.